Fibrosis of extrahepatic biliary system after continuous hepatic artery infusion of floxuridine through an implantable pump (infusaid pump)
- 1 April 1986
- Vol. 57 (7) , 1281-1283
- https://doi.org/10.1002/1097-0142(19860401)57:7<1281::aid-cncr2820570704>3.0.co;2-b
Abstract
A case of severe fibrosis of the extrahepatic biliary system after hepatic artery infusion of floxuridine is described. The clinical and pathologic features are presentedand its pathogenesis discussed. The authors suggest investigation of an alternate drug schedule and/or dosage of floxuridine to eliminate or minimize this serious complication.This publication has 8 references indexed in Scilit:
- Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.Journal of Clinical Oncology, 1985
- Hepatic Arterial Chemotherapy for Colorectal Cancer Metastatic to the LiverAnnals of Internal Medicine, 1984
- Peptic ulceration with marked epithelial atypia following hepatic arterial infusion chemotherapyThe American Journal of Surgical Pathology, 1983
- Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump: A feasibility study in 50 patientsThe American Journal of Surgery, 1983
- The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: Ten-year results of 124 patients in a prospective protocolCancer, 1981
- Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): An effective treatment for metastatic colorectal carcinoma in the liverCancer, 1980
- CLINICAL-PHARMACOLOGICAL EVALUATION OF HEPATIC ARTERIAL INFUSIONS OF 5-FLUORO-2'-DEOXYURIDINE AND 5-FLUOROURACIL1978